Cargando…

Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees

BACKGROUND: Residents of nursing homes are one of the most vulnerable groups during the severe acute syndrome coronavirus 2 (SARS-CoV-2) pandemic. The aim of this study was to characterize cellular and humoral immune responses in >70-year-old participants before vaccination, after first and secon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jäger, Michael, Sonnleitner, Sissy Therese, Dichtl, Stefanie, Lafon, Eliott, Diem, Gabriel, Walder, Gernot, Lass-Flörl, Cornelia, Wilflingseder, Doris, Posch, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271971/ https://www.ncbi.nlm.nih.gov/pubmed/35833113 http://dx.doi.org/10.3389/fimmu.2022.868361

Ejemplares similares

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
por: Diem, Gabriel, et al.
Publicado: (2023)

Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model
por: Luvanda, Maureen K., et al.
Publicado: (2021)

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections
por: Dichtl, Stefanie, et al.
Publicado: (2022)

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
por: Jäger, Michael, et al.
Publicado: (2022)

ColdZyme® protects airway epithelia from infection with BA.4/5
por: Viktoria, Zaderer, et al.
Publicado: (2022)

Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
por: Zaderer, Viktoria, et al.
Publicado: (2023)

SARS-CoV-2–infected primary human airway epithelia illustrate mucus hypersecretion
por: Posch, Wilfried, et al.
Publicado: (2021)

Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2023)

Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
por: Jäger, Michael, et al.
Publicado: (2023)

Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation
por: Dichtl, Stefanie, et al.
Publicado: (2023)

The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2022)

Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity
por: Posch, Wilfried, et al.
Publicado: (2020)

Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model
por: Zaderer, Viktoria, et al.
Publicado: (2019)

Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
por: Lafon, Eliott, et al.
Publicado: (2021)

An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value
por: Therese, Sonnleitner Sissy, et al.
Publicado: (2021)

Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2021)

Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
por: Diem, Gabriel, et al.
Publicado: (2023)

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021)

Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
por: Masson, Letícia Carrijo, et al.
Publicado: (2023)

Dynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine
por: Sheehan, Jared, et al.
Publicado: (2023)

Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2022)

Dexamethasone Promotes Aspergillus fumigatus Growth in Macrophages by Triggering M2 Repolarization via Targeting PKM2
por: Luvanda, Maureen K., et al.
Publicado: (2021)

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees
por: Low, Jia Ming, et al.
Publicado: (2021)

Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technology
por: Schöbel, H., et al.
Publicado: (2023)

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
por: Hurme, Antti, et al.
Publicado: (2022)

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
por: Mileto, D., et al.
Publicado: (2022)

Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients
por: Fuchs, Stefan, et al.
Publicado: (2019)

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New
por: Lackner, Nina, et al.
Publicado: (2021)

Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
por: Posch, Wilfried, et al.
Publicado: (2021)

BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees
por: Alghamdi, Ahmed N., et al.
Publicado: (2021)

Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents
por: Reis, Ben Y., et al.
Publicado: (2021)

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
por: Van Coillie, Julie, et al.
Publicado: (2022)

Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2021)

Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata
por: Knoll, Miriam Alisa, et al.
Publicado: (2022)

Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity
por: Schönfeld, Manuela, et al.
Publicado: (2019)

ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
por: Posch, W., et al.
Publicado: (2021)

Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general population
por: Tschiderer, Lena, et al.
Publicado: (2022)

Wie sich COVID-19 in der 3D-Zellkultur simulieren lässt
por: Wilflingseder, Doris, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62i41us40bhji6vi3q9v9shmjr